CN101812458A - Rachycentron canadus MHC-IIalpha gene sequence - Google Patents

Rachycentron canadus MHC-IIalpha gene sequence Download PDF

Info

Publication number
CN101812458A
CN101812458A CN201010109630A CN201010109630A CN101812458A CN 101812458 A CN101812458 A CN 101812458A CN 201010109630 A CN201010109630 A CN 201010109630A CN 201010109630 A CN201010109630 A CN 201010109630A CN 101812458 A CN101812458 A CN 101812458A
Authority
CN
China
Prior art keywords
mhc
gene
iialpha
rachycentron
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010109630A
Other languages
Chinese (zh)
Inventor
冯娟
茅莉娜
侯月娥
苏友禄
徐力文
郭志勋
王江勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Sea Fisheries Research Institute Chinese Academy Fishery Sciences
Original Assignee
South China Sea Fisheries Research Institute Chinese Academy Fishery Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Sea Fisheries Research Institute Chinese Academy Fishery Sciences filed Critical South China Sea Fisheries Research Institute Chinese Academy Fishery Sciences
Priority to CN201010109630A priority Critical patent/CN101812458A/en
Publication of CN101812458A publication Critical patent/CN101812458A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a rachycentron canadus MHC-IIalpha gene sequence, the DNA nucleotide thereof and corresponding amino acid sequence are shown as SEQ ID NO. 1. The gene not only lays the foundation for researching action mechanism of fish MHC-IIalpha molecule and relation of MHC-IIalpha gene polymorphism with fish premonition, but also purified protein with biological activity can be obtained by virtue of the gene sequence, and research of novel disease-resistant immune antibody can be implemented.

Description

Rachycentron canadus MHC-IIalpha gene sequence
Technical field
What the present invention relates to is a kind of albumen coded sequence, especially relates to a kind of cabio MHC-II α gene order.
Background technology
MHC (major histocompatibility complex) is a major histocompatibility complex, is meant compound genetic system or the zone with height polymorphism be made up of a series of closely linked gene locus on the karyomit(e).Be that a class cell surface by MHC coding changes membranin, can in conjunction with and present endogenous antigen and exogenous antigen to the T lymphocyte.Different according to chemical structure and function, MHC can be divided into MHCI quasi-molecule and mhc class ii molecule.Wherein, mostly the antigen of II class MHC molecular presentation is the cell exogenous polypeptid, it is assembled into complete tripolymer by α, β and accessory molecule γ chain in endoplasmic reticulum, protease hydrolysis γ chain, antigenic peptide combines with II class MHC molecule, forms steady I I class MHC-complex of polypeptides, is transported to cell surface again, exogenous antigen is assisted T lymphocyte (Th, CD4 with being after the mhc class ii molecule combines to pass in plastosome or lysosome +), thereby trigger immune response.Fish mhc class ii molecule is formed a heterodimer by a chain and β chain with the form of non covalent bond.
The inducing and regulating of MHC wide participation immunne response, the excitating organism specific immune response has very important meaning on immunology.Since MHC have polymorphism, with the dependency and the linkage disequilibrium of disease, therefore, understand the structure and the function of fish mhc gene, seek tumor susceptibility gene or disease resistance gene with the disease-related connection, preventing disease is had very high value.In addition, because the height polymorphism of MHC, thus can be used for population genetics research, and as one of mark of population molecular evolution.Moreover, the polymorphism that MHC has, can be used for the disease-resistant strain of seed selection with the characteristics such as related and linkage disequilibrium of disease.
Summary of the invention
The purpose of this invention is to provide a kind of cabio MHC-II α gene order.
The present invention passes through the degenerate primer with the conserved regions design of the CDS sequence of nearly source species MHC-II α gene, and increases with the PCR method, is cloned into the full expressed sequence of cabio MHC-II α chain gene in conjunction with the RACE technology; By to MHC-II α gene design primers designed effectively, thereby can analyze the tissue distribution situation of this gene, and the expression amount of the MHCII α in the post-stimulatory spleen of LPS is analyzed by quantitative fluorescent PCR.Concrete DNA Nucleotide and amino acid sequence corresponding are as follows:
agtcgactctaagattcacagacgctcagctcagtgacctgctgctgacgaagatgatga 60
><
M M 2
tcaagctgctcctcttcctcccctgtctcatctctgtctctgctgaaagtctccatgtgg 120
Leader?pept?i?de >< α1?domain
I K L L L F L P C P I S V S A E S L H V 22
accttgctatcactggctgttcagactctgatggagaggatatgtactctctggatggag 180
D L A I T G C S D S D G E D M Y S L D G 42
aagagatgtggtttgcagacttcgtcaatcaaaggggagtggagcctcagcccagcttcg 240
E E M W F A D F V N Q R G V E P Q P S F 62
tagatcatattggctacgtgaatggaacttatgaaggagctgtgaccaatcaacagatct 300
V D H I G Y V N G T Y E G A V T N Q Q I 82
gcaggtcaaacctgaagaacagtcgtgtcggtatgaaggacatccccctggaaaatgatc 360
><α2?domain
C R S N L K N S R V G M K D I P L E N D 102
ctccttccacgctcatcatctacagcagagacgaggtggagatcggagaggagaacgtcc 420
P P S T L I I Y S R D E V E I G E E N V 122
tgatctgttacgtgtctgggttctaccctgctcctgtcaaagtccactggaccaagaacg 480
L I C Y V S G F Y P A P V K V H W T K N 142
gagagagcgtgactgagggaacgagtatcaatgttccctatccgaacaaagacggttcct 540
G E S V T E G T S I N V P Y P N K D G S 162
tcaaccagatatccagactgaacttcatcccacagcagggagacatgtacagctgctcag 600
F N Q I S R L N F I P Q Q G D M Y S C S 182
tgacacatccagctctgcaacaacgcatgaccaggatctgggatgtggacgtgcagcagc 660
>< CP/TM/CYT?region
V T H P A L Q Q R M T R I W D V D V Q Q 202
ccagtatcggacctgcggtgttctgtggcctcggtctgacggtcggtttgcttggtgtcg 720
P S I G P A V F C G L G L T V G L L G V 222
cagctggaaccttcttcctcatcaaaggaaacgagtgcagctaattggctggagctgatg 780
A A G T F F L I K G N E C S * 236
atgtcatcagttttttttttttgtatagtgtcctatcaggcttcacctgcttcagagaat 840
cagctgtttatgataatgatgtaaataatcatcttcatcttcatcatctcacttcttaaa 900
aatcactaaaccagatgtcgatgttctgtgatcagctactataaacttcctctttcaaaa 960
taaaagtccagtctcttaatgcaaaaaaaaaaaaaaaa 998
The acquisition of advantage of the present invention: Ben Jiyin not only lays the foundation for the relation of the mechanism of action of researching fish MHC-II α quasi-molecule and MHC-II α gene pleiomorphism and fish body disease resistance, and can obtain the purifying protein of biologically active by gene order, become a reality for studying novel anti pathologic immunity antibody.This gene provides material for fish population genetics and evolutionary genetics research, can be used for population genetics research, and as one of mark of population molecular evolution.Simultaneously can carry out the research of disease-resistant dependency and disease-resistant assistant breeding.
Description of drawings
Fig. 1 is the distribution of the present invention in the cabio healthy tissues;
Fig. 2 is the present invention's MHC-II α gene expression variation diagram in time in the cabio spleen tissue after LPS stimulates.
Embodiment
1. the extraction of total RNA
Get healthy cabio (the about 1000g of body weight) and in culturing bucket, culture after 3 days the shark vibrio of abdominal injection 1ml (JT2).After stimulating 192h, dissect the fish body and take out the about 250mg of spleen, it is standby to put into-80 ℃ of refrigerators.Get the about 100mg of standby tissue and carry out homogenate, extract total RNA according to the test kit explanation with the Trizol (U.S. invitrogen company) that scissors shreds adding 1ml.
2.cDNA first chain is synthetic
Getting the total RNA5 μ of cabio g mixes with reverse transcription primer (oligodT joint primer) 1 μ l (10pmol/L), behind 65 ℃ of heating 5min, place immediately and leave standstill 2min on ice, add 5 * buffer then, the 10mmol/LdNTP mixed solution, Ribonuclease Inhibitor, M-MLV ThermoScript II, reaction system are 20 μ l.Response procedures is 37 ℃, 60min, and it is standby to put into-80 ℃ of preservations at last.
3. design of primers foundation, primer synthetic method
From GenBank, download nearly source species (as people, mouse, rainbow trout etc.) MHCII-α homologous gene CDS sequence, utilize Clustal W software to carry out the multisequencing comparison, determine conserved regions, according to conserved regions sequences Design degenerate primer (J2AF, J2AR), the amplified fragments size is about 324bp.Submitting to English fine horse biotechnology Services Co., Ltd to carry out DNA after the design of primers synthesizes.
4. to the clone of cabio MHC-II α gene cDNA complete sequence
With the degenerate primer (J2AF, J2AR) of the conserved regions design of nearly source species MHC-II α gene C DS sequence, the amplified fragments size is about 324bp.
As template, carry out pcr amplification with degenerate primer with the above-mentioned synthetic first chain cDNA, institute's amplification PCR products detects with 1% agarose gel electrophoresis, and purifying reclaims the purpose product from gel.Then with the PCR product cloning of purifying in the pMD-18T carrier, transformed into escherichia coli TOP 10 competent cells, the picking positive colony extracts plasmid DNA.After degenerated primer PCR detects, will have the segmental plasmid DNA of insertion and carry out two-way order-checking with the M13 universal primer.
According to the cDNA fragment sequence design Auele Specific Primer (RCMC32AOUT, RCMC32AIN, RCMC52AOUT, RCMC52AIN) that has obtained, utilize the terminal rapid amplifying technology of cDNA (Rapid Amplificationof cDNA ends, RACE) to 3 of goal gene ' and 5 ' end carry out pcr amplification.
In 3 ' RACE, utilize half-nest type (semi-nested) PCR method, at first carry out the PCR reaction by outside primer RCMC32AOUT and 3 ' joint primer SMART 3a, products therefrom utilizes inboard Auele Specific Primer RCMC32AIN and 3 ' joint primer SMART 3a to carry out pcr amplification again.
In 5 ' RACE, utilize terminal enzyme (DNA) and dCTP after the cDNA end adds poly (C) tail, with the cDNA behind the tailing as template, utilize outside Auele Specific Primer RCMC52AOUT and OligodG to carry out the pcr amplification first time, gained PCR product utilizes inboard primer RCMC52AIN and OligodG to carry out the pcr amplification second time again.
Resulting PCR product is after carrying out separation detection on 1% the agarose gel electrophoresis, behind the PCR product purification, be cloned in the pMD-18T carrier, transformed into escherichia coli TOP 10 competent cells, the picking positive colony, with the M13 primer plasmid DNA is checked order, order-checking institute calling sequence utilizes DNAStar software to splice with the sequence of degenerate primer amplification gained again.
5. to the mensuration of cabio MHC-II α gene
Resulting PCR product behind the PCR product purification, is cloned in the pMD-18T carrier transformed into escherichia coli TOP10 competent cell, picking positive colony after carrying out separation detection on 1% the agarose gel electrophoresis.Sequencing result carries out homology with BLAST software to be measured, and is defined as cabio MHC-II α dna homolog sequence.
6, the RT-PCR of MHC-II α gene in different tissues analyzes
Get healthy tissues such as cabio (185g) heart, spleen, the gill, head-kidney, muscle, the heart, intestines and brain, the first chain cDNA is a template with the reverse transcription synthetic, application Real-time PCR detection method has carried out studying (β-ActinF to the MHC-II α gene organization expression characteristic of cabio, β-ActinR, J2AF, J2AR).As shown in Figure 1, MHC-II α gene all has expressed in normal cabio tissue, and wherein stronger is expressed in the head-kidney, and the moderate gill, spleen, the brain of being expressed in is in the heart, intestines, muscle a little less than the expression.
7, RT-PCR detects the expression of MHC-II α mRNA
Extraction is through the spleen tissue RNA of the different time points of LPS stimulation, and the first chain cDNA is a template with the reverse transcription synthetic, and expression regulation rule in the post-stimulatory spleen of application Real-time PCR detection LPS (β-ActinF, β-ActinR, J2AF, J2AR).Utilize 2 -Δ Δ CTMethod is calculated relative expression quantity, and as shown in Figure 2, MHC-II α genetic expression presents downward trend after LPS stimulates, and all has significant difference with respect to control group.
The primer that the present invention uses sees the following form:
Figure GSA00000029095000051
Sequence table
<110〉Nanhai Aquatic Inst., Chinese Aquatic Scientific Research Inst
 
<120〉cabio MHC-II α gene order
 
<160>2
 
<210>1
 
<211>998
 
<212>RNA
 
<213〉cabio (Rachycentron canadium)
 
<220>
 
<221>3’UTP
 
<222>(765)...(998)
 
<220>
 
<221>5’UTR
 
<222>(1)...(53)
 
<220>
 
<221>CDS
 
<222>(54)...(764)
 
<220>
 
<221>PolyA?site
 
<222>(983)...(998)
 
<400>1
 
agtcgactctaagattcacagacgctcagctcagtgacctgctgctgacgaagatgatga 60
><
M M 2
tcaagctgctcctct?tcctcccctgtctcatctctgtctctgctgaaagtctccatgtgg 120
Leader?peptide >< α1?domain
I K L L L F L P C P I S V S A E S L H V 22
accttgctatcactggctgttcagactctgatggagaggatatgtactctctggatggag 180
D L A I T G C S D S D G E D M Y S L D G 42
aagagatgtggtttgcagacttcgtcaatcaaaggggagtggagcctcagcccagcttcg 240
E E M W F A D F V N Q R G V E P Q P S F 62
tagatcatattggctacgtgaatggaacttatgaaggagctgtgaccaatcaacagatct 300
V D H I G Y V N G T Y E G A V T N Q Q I 82
gcaggtcaaacctgaagaacagtcgtgtcggtatgaaggacatccccctggaaaatgatc 360
><α2?domain
C R S N L K N S R V G M K D I P L E N D 102
ctccttccacgctcatcatctacagcagagacgaggtggagatcggagaggagaacgtcc 420
P P S T L I I Y S R D E V E I G E E N V 122
tgatctgttacgtgtctgggttctaccctgctcctgtcaaagtccactggaccaagaacg 480
L I C Y V S G F Y P A P V K V H W T K N 142
gagagagcgtgactgagggaacgagtatcaatgttccctatccgaacaaagacggttcct 540
G E S V T E G T S I N V P Y P N K D G S 162
tcaaccagatatccagactgaacttcatcccacagcagggagacatgtacagctgctcag 600
F N Q I S R L N F I P Q Q G D M Y S C S 182
tgacacatccagctctgcaacaacgcatgaccaggatctgggatgtggacgtgcagcagc 660
>< CP/TM/CYT?region
V T H P A L Q Q R M T R I W D V D V Q Q 202
ccagtatcggacctgcggtgttctgtggcctcggtctgacggtcggtttgcttggtgtcg 720
P S I G P A V F C G L G L T V G L L G V 222
cagctggaaccttcttcctcatcaaaggaaacgagtgcagctaattggctggagctgatg 780
A A G T F F L I K G N E C S * 236
atgtcatcagttttttttttttgtatagtgtcctatcaggcttcacctgcttcagagaat 840
cagctgtttatgataatgatgtaaataatcatcttcatcttcatcatctcacttcttaaa 900
aatcactaaaccagatgtcgatgttctgtgatcagctactataaacttcctctttcaaaa 960
taaaagtccagtctcttaatgcaaaaaaaaaaaaaaaa 998
 
<210>2
 
<211>236
 
<212>PRT
 
<213〉cabio (Rachycentron canadium)
 
<400>2
 
MMIKLLLFLPCLISVSAESLHVDLAITGCSDSDGEDMYSLDGEEMWFADFVNQRGVEPQP 60
SFVDHIGYVNGTYEGAVTNQQICRSNLKNSRVGMKDIPLENDPPSTLIIYSRDEVEIGEE 120
NVLICYVSGFYPAPVKVHWTKNGESVTEGTSINVPYPNKDGSFNQISRLNFIPQQGDMYS 180
CSVTHPALQQRMTRIWDVDVQQPSIGPAVFCGLGLTVGLLGVAAGTFFLIKGNECS 236

Claims (1)

1. cabio MHC-II α gene order chain gene sequence is characterized in that: its DNA Nucleotide and amino acid sequence corresponding are as described in the SEQ ID NO.1.
CN201010109630A 2010-02-05 2010-02-05 Rachycentron canadus MHC-IIalpha gene sequence Pending CN101812458A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010109630A CN101812458A (en) 2010-02-05 2010-02-05 Rachycentron canadus MHC-IIalpha gene sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010109630A CN101812458A (en) 2010-02-05 2010-02-05 Rachycentron canadus MHC-IIalpha gene sequence

Publications (1)

Publication Number Publication Date
CN101812458A true CN101812458A (en) 2010-08-25

Family

ID=42619825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010109630A Pending CN101812458A (en) 2010-02-05 2010-02-05 Rachycentron canadus MHC-IIalpha gene sequence

Country Status (1)

Country Link
CN (1) CN101812458A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105208855A (en) * 2013-03-11 2015-12-30 瑞泽恩制药公司 Genetically modified mice expressing chimeric major histocompatibility complex (MHC) II molecules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105208855A (en) * 2013-03-11 2015-12-30 瑞泽恩制药公司 Genetically modified mice expressing chimeric major histocompatibility complex (MHC) II molecules
CN105208855B (en) * 2013-03-11 2018-04-27 瑞泽恩制药公司 The transgenic mice of chimeric major histocompatibility complex (MHC) the II quasi-molecules of expression

Similar Documents

Publication Publication Date Title
US12024719B2 (en) Transgenic macrophages, chimeric antigen receptors, and associated methods
Kulski et al. Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark to man
Hanes et al. A genetic model for interaction of the homeodomain recognition helix with DNA
Gan et al. Molecular characterization and expression of CD2BP2 in Nile tilapia (Oreochromis niloticus) in response to Streptococcus agalactiae stimulus
KR102508182B1 (en) Transformed macrophages, chimeric antigen receptors, and related methods
US11091531B2 (en) Antigen-specific helper T-cell receptor genes
JPS60115528A (en) Human interleukin-2 protein, its production and pharmacological composition containing the same
US20210052643A1 (en) Modified macrophages and macrophage precursors and associated methods
Santos et al. The granulocyte colony-stimulating factors (CSF3s) of fish and chicken
Li et al. Molecular cloning, promoter analysis and induced expression of the complement component C9 gene in the grass carp Ctenopharyngodon idella
CN101812458A (en) Rachycentron canadus MHC-IIalpha gene sequence
KR100381711B1 (en) Peptides and pharmaceutical compositions comprising them
Kurobe et al. Molecular cloning, characterization, expression and functional analysis of Japanese flounder Paralichthys olivaceus Fas ligand
CN101709302A (en) Cobia MHC-II beta gene sequence
Piyaviriyakul et al. A novel immune-type receptor of Japanese flounder (Paralichthys olivaceus) is expressed in both T and B lymphocytes
CN103739696B (en) Cynoglossus semilaevis female specificity CSW3 protein as well as gene and application thereof
CN107557366B (en) Epinephelus coioides natural immune receptor TLR13 gene, eukaryotic expression vector and application thereof
CN101988065A (en) Haliotis diversicolor calmodulin cDNA sequence
Holm et al. Cloning and characterization of SCART1, a novel scavenger receptor cysteine-rich type I transmembrane molecule
Walter et al. Physical mapping of the Ring1, Ring2, Ke6, Ke4, Rxrb, Col11a2, and RT1. Hb genes in the rat major histocompatibility complex
US20030166300A1 (en) Growth-related inflammatory and immune response protein
Li et al. Expression of Hsp70 reveals significant differences between fin regeneration and inflammation in Paramisgurnus dabryanus
CN108715851A (en) A kind of Epinephelus coioides are ingested regulation and control related gene AgRP1 and its application
Shinkai et al. Genomic structure of eight porcine chemokine receptors and intergene sharing of an exon between CCR1 and XCR1
CN103060347B (en) Recombinant carp PKC delta gene and recombinant carp PKC delta protein as well as preparation method, detection method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100825